These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1349436)

  • 1. Effects of chronic SCH 23390 or acute EEDQ on the discriminative stimulus effects of SKF 38393.
    Cao GH; Perry BD; Woolverton WL
    Pharmacol Biochem Behav; 1992 Feb; 41(2):321-7. PubMed ID: 1349436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the interaction between D1 and D2 receptors in a drug discrimination paradigm.
    Williams JE; Sutherland JV; Woolverton WL
    Behav Neural Biol; 1990 May; 53(3):378-92. PubMed ID: 1972014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of D1 and D2 dopamine agonists in rats.
    Kamien JB; Goldberg LI; Woolverton WL
    J Pharmacol Exp Ther; 1987 Sep; 242(3):804-11. PubMed ID: 2958620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
    Wachtel SR; Brooderson RJ; White FJ
    Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The D1 dopamine agonist SKF 38393 functions as a discriminative stimulus in rats.
    Kamien JB; Woolverton WL
    Psychopharmacology (Berl); 1985; 87(3):368-70. PubMed ID: 2934759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA; Widzowski DV; Newland MC
    J Pharmacol Exp Ther; 1989 Sep; 250(3):800-8. PubMed ID: 2789282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective protection from the inhibition by EEDQ of D1 and D2 dopamine agonist-induced rotational behavior in mice.
    Goodale DB; Jacobi AG; Seyfried DM; Weiss B
    Pharmacol Biochem Behav; 1988 Jun; 30(2):457-62. PubMed ID: 2902647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
    Williams JE; Woolverton WL
    Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine D(1) receptor agonist SKF-82958 serves as a discriminative stimulus in the rat.
    Haile CN; Carey G; Varty GB; Coffin VL
    Eur J Pharmacol; 2000 Jan; 388(2):125-31. PubMed ID: 10666503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A full repetitive jaw movement response after 70% depletion of caudate D1 receptors.
    Rosengarten H; Schweitzer JW; Friedhoff AJ
    Pharmacol Biochem Behav; 1989 Dec; 34(4):895-7. PubMed ID: 2533692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Saller CF; Kreamer LD; Adamovage LA; Salama AI
    Life Sci; 1989; 45(10):917-29. PubMed ID: 2529407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists.
    Desai RI; Terry P; Katz JL
    Behav Pharmacol; 2003 May; 14(3):223-8. PubMed ID: 12799524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective dopamine receptor agonists in rats trained to discriminate apomorphine from saline.
    Woolverton WL; Kamien JB; Goldberg LI
    Pharmacol Biochem Behav; 1985 Apr; 22(4):577-81. PubMed ID: 3873077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the selectivities of SCH 23390 with BW737C89 for D1, D2 and 5-HT2 binding sites both in vitro and in vivo.
    Riddall DR
    Eur J Pharmacol; 1992 Jan; 210(3):279-84. PubMed ID: 1351844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.